Latest Period
Q1 2026
CUSIP: 74880P104
Latest Period
Q1 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$3.64
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 0 institutions filings for Q1 2026.
Security key
74880P104
Latest holder period
Q1 2026
13F holders
0
13D/G owners
4
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 74880P104:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Lakeview Opportunity Fund LLC | 8% | $9,044,115 | 3,465,178 | Lakeview Opportunity Fund LLC | 31 Oct 2025 | |||
| Claret Asset Management Corp | 7.3% | -30% | $11,449,847 | -$4,421,490 | 3,225,309 | -28% | Claret Asset Management Corporation | 31 Dec 2025 |
| GLAZER CAPITAL, LLC | 5.6% | $8,752,372 | 2,476,409 | Glazer Capital, LLC | 08 Jan 2026 | |||
| Philotimo Fund, LP | 4.4% | -36% | $4,092,717 | -$2,202,710 | 1,930,527 | -35% | Kanen David | 20 May 2025 |
As of 31 Mar 2026, 0 institutional investors reported holding 0 shares of Quipt Home Medical Corp. - Common Shares (QIPT). This represents 0% of the company’s total 44,001,487 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$63,664,617 | $3.64 | 0 |
| 2025 Q4 | 19,660,086 | $69,403,088 | +$1,029,811 | $3.53 | 70 |
| 2025 Q3 | 20,935,971 | $54,686,095 | +$822,374 | $2.61 | 59 |
| 2025 Q2 | 20,910,676 | $37,439,271 | -$11,284,731 | $1.79 | 74 |
| 2025 Q1 | 25,306,219 | $58,921,860 | -$7,361 | $2.33 | 87 |
| 2024 Q4 | 23,900,546 | $72,868,949 | +$3,561,465 | $3.05 | 92 |
| 2024 Q3 | 22,735,923 | $66,278,287 | +$6,002,601 | $2.92 | 91 |
| 2024 Q2 | 20,527,909 | $66,131,637 | +$3,267,770 | $3.22 | 87 |
| 2024 Q1 | 18,796,492 | $82,150,697 | +$5,954,179 | $4.37 | 79 |
| 2023 Q4 | 18,103,721 | $92,182,343 | -$3,591,149 | $5.09 | 83 |
| 2023 Q3 | 18,808,213 | $95,868,798 | +$7,877,309 | $5.09 | 87 |
| 2023 Q2 | 17,233,237 | $92,134,619 | +$21,492,644 | $5.34 | 90 |
| 2023 Q1 | 13,041,001 | $91,505,194 | +$20,883,773 | $7.01 | 67 |
| 2022 Q4 | 10,054,727 | $47,162,293 | +$3,643,311 | $4.71 | 35 |
| 2022 Q3 | 9,286,985 | $38,491,288 | +$10,178,184 | $4.16 | 35 |
| 2022 Q2 | 6,820,322 | $31,346,169 | +$4,055,057 | $4.62 | 31 |
| 2022 Q1 | 5,944,197 | $26,217,682 | -$2,613,131 | $4.39 | 29 |
| 2021 Q4 | 6,367,419 | $35,685,500 | +$3,068,532 | $5.61 | 38 |
| 2021 Q3 | 5,810,948 | $36,401,374 | +$5,887,664 | $6.29 | 33 |
| 2021 Q2 | 4,879,915 | $30,385,060 | +$30,312,060 | $6.26 | 26 |
| 2021 Q1 | 37,700 | $73,000 | +$73,000 | $1.94 | 1 |